AtriCure Raises FY2026 GAAP EPS Guidance from $0.00-$0.04 to $0.05-$0.13 vs $0.05 Est

Benzinga Newsdesk www.benzinga.com Positive 93.8%

Neg 0% Neu 0% Pos 93.8%

AtriCure (NASDAQ:ATRC) raises FY2026 GAAP EPS guidance from $0.00-$0.04 to $0.05-$0.13 vs $0.05 analyst estimate..

Comments

No comments yet. Be the first!